2022 Nephron Pharmacy Benefit Management Innovation Symposium

The 2022 Benefit Innovation Symposium will center on three key topics:

• Preparing for Humira: We will examine PBM, Payor and Employer biosimilar strategies for 2023 and beyond.
• Rebate Contracting Entities: A deep dive into Cigna’s Ascent and Prime’s emergence as the aggregator of aggregators.
• New & Disruptive Models:  Our picks for potential disruption: ‘New Payor’ (Evio), ‘New PBM’ (Emsana & CapitalRx), ‘New Pharma’ (EQRx & Biosim Mfrs.), and many more…

email info@nephronresearch.com for information on attendance.